After 24 weeks of treatment with either placebo, Pegozafermin 15 mg weekly, Pegozafermin 30 mg weekly, or Pegozafermin 44 mg every two weeks, the proportions of patients achieving fibrosis improvement were 7%, 22%, 26%, and 27%, respectively
It helps regulate insulin release based on blood sugar levels, slows gastric emptying to promote satiety, and reduces appetite
Months 3-6 and beyond: Continued improvement and maintenance Improvement typically continues beyond the 12-week point, though the rate of change slows compared to the initial phase
The effect of semaglutide on weight loss observed in the STEP 1 trial was greater than that of liraglutide, the first GLP-1 RA approved for weight management, in obese subjects not affected by diabetes treated with liraglutide 3.0 mg once daily in SCALE trial [9]
But it was soon realized that these drugs came with a bonus, since GLP-1 doesnt act only on the pancreas
According to Austin Chen, a registered pharmacist at Express Scripts, Patients should be aware of signs and symptoms of internal bleeding